The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Post Tagrisso***
Comments
-
Sorry you're going through this . it must be incredibly frustrating. I don't have an EGFR mutation but here's what I can pass along.
When Tagrisso stops working, the next steps depend heavily on what new mutations may have emerged or what’s believed to be driving resistance. Fortunately, there are some promising new options to consider.
• Targeted combinations like lazertinib + amivantamab. This combo has shown encouraging results, especially in cases where MET amplification or other EGFR-related resistance pathways are involved. It’s already approved in some settings after Tagrisso resistance. It was approved in 2024.
• Next-generation antibody-drug conjugate Drugs like datopotamab deruxtecan are designed to deliver chemotherapy directly to cancer cells using a TROP2-targeting antibody, limiting collateral damage to healthy tissue.It was just approved for EGFR mutated lung cancer as a 2nd line treatment.
Both are cutting-edge options. the NCCN recommends a liquid biopsy on progression with EGFR mutated lung cancers.. that is your best first step in choosing the right path
-
-
Yes it's a MET 14 targeted drug currently in clinical trials. MET 14 can be an acquired resistance pathway in EGFR Cancers so it very well be an option. The first step is the liquid biopsy to find her best potions.
One of my favorite sites is Vanderbilts My Cancer Genome . It's all about cancer genetic drivers and their treatments and clinical trials.
While it's not doubt scary, cancer treatments are advancing rapidly.
-
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 455 Bladder Cancer
- 311 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards